This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership. Peptide plants inherited API chemistry thinking and oligo plants biotech thinking; ISPE’s guide puts both modalities in one facility document with both…
Cerenome Secures National In-Network Agreement with Aetna for CNSide® BuzzFeed, Inc. Reports Q3 2026 Financial Results HUTCHMED Announces Sovleplenib Granted US FDA Orphan Drug Designation for Autoimmune Hemolytic Anemia GOLD ROYALTY REPORTS RECORD THREE AND NINE-MONTH RESULTS WITH CONTINUED STRONG CASH FLOW…
Elong Power Holding Limited (NASDAQ: ELPW) Announces Subsidiary’s Entry into a Three-Year Cooperation Agreement Worth at least RMB2 Billion (～US$300 Million), Achieving a Major Breakthrough in Domestic Grid-Side Energy Storage Supply Hertz Announces Q3 2026 Results, Strongest Quarterly Revenue and EBITDA Performance in…
Local medical manufacturing is not new. The Commonwealth Serum Laboratories was set up during the First World War because the country needed to make vaccines and biological products itself when overseas supply was cut off. The Australian Government floated it…
This week's sector commentary on regulatory wins and a positive tone toward British healthcare has widened the circle of names being discussed, and smaller specialists have benefited from that attention. Analysts who follow the group typically stress that its results…
Waters Corporation bought MOBILion Systems and its ion mobility technology to enter LC-MS proteomics, a market Waters sizes at $2 billion. Its existing business grew 9% to $871 million on routine drug and environmental testing. Proteomics is still a research bet. This story…
Wednesday, 4 November 2026 | Global Edition By Sabrina Valle, Milana Vinn and Amy-Jo Crowley Nov 4 (Reuters) - AstraZeneca made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people familiar with the matter. AstraZeneca offered as much as…
What Makes InPlay Oil (TSX:IPO) Dividend Worth Watching Today? That structure means HLS is not taking on the regulatory file or the safety-reporting obligations that come with being the authorization holder. Instead, the arrangement concentrates HLS on the parts…
Wednesday, 4 November 2026 | Global Edition AbbVie has unveiled a £120 million-plus (£120 m) investment to expand its Oxford R&D facility by 12,000 sq ft, enhancing capabilities across immunology, neuroscience and oncology and leveraging its 2022 DJS Antibodies acquisition. The expansion boosts UK R&D…
This analysis sticks to what the launch coverage supports. Several details that readers will want, including the name of the model and the identity of the one reported customer, are not public. Where the record is thin, this piece says…
Biotechnology, gene editing, biopharma platforms, and clinical pipelines.
An article joins this feed when it matches these terms. Each one is also a search of its own.